Ignite Creation Date:
2024-05-06 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04722848
Status:
RECRUITING
Last Update Posted:
2024-02-07
First Post:
2021-01-20
Brief Title:
Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph ALL
Sponsor:
Gruppo Italiano Malattie EMatologiche dellAdulto
Organization:
Gruppo Italiano Malattie EMatologiche dellAdulto
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Philadelphia-Positive ALL |
| Acute Lymphoblastic Leukemia Philadelphia Chromosome Positive |
| ALL Adult |
Keywords: